See which drugs and companies are entering and exiting the market by monitoring new drug launches and patent expirations.
Pinpoint the openings to challenge weak patents and be the first to file generics by tracking drug patent litigations, EP oppositions, family trees, and para IV filings.
Discover companies who have already filed for the generic of a drug to stay ahead in making informed decisions on partnerships, investments, and competitive strategies.
Get access to exclusive reports on collaboration opportunities, blockbuster drug patent expiration, and other strategic developments shaping the pharmaceutical landscape.
Our insights are consumed by 1000+ leading pharma companies